胱抑素C评估肾脏功能储备预测慢性肾脏病结局
本研究在3-4期慢性肾脏病患者中,通过口服蛋白负荷后系列血浆胱抑素C测量肾脏功能储备(KFR),并与肌酐清除率和99mTc-DTPA测量的GFR比较。结果显示三种方法一致性良好,KFR与基线肾功能无关。胱抑素C KFR和基线血肌酐可预测死亡或透析或复合肾脏不良事件,联合年龄、基线血肌酐和最低胱抑素C可预测eGFR快速下降。
要点
- 胱抑素C系列测量可替代尿液收集和放射性核素评估KFR。
- KFR与基线肾功能不相关,提示其独立预测价值。
- 胱抑素C KFR联合基线血肌酐等可预测CKD进展和不良结局。
核心结论
- 系列胱抑素C测量可提供与肌酐清除率和99mTc-DTPA mGFR相当的KFR估计,避免定时尿收集和放射性暴露。
- 胱抑素C KFR和基线血肌酐可预测死亡或透析或MAKE-F,联合年龄、基线血肌酐和最低胱抑素C可预测eGFR快速下降(MAKE-S)。
研究设计与样本
- 观察性、单中心队列研究,纳入19例CKD 3期和21例CKD 4期成人患者。
- 低蛋白饮食24小时后口服蛋白负荷,每小时测量血浆胱抑素C、肌酐清除率和99mTc-DTPA mGFR,随访3年。
主要发现
- 胱抑素C、肌酐清除率和99mTc-DTPA mGFR测量的KFR一致性良好。
- KFR与基线肾功能不相关。
- 8例(42%)CKD 3期和11例(52%)CKD 4期患者在蛋白负荷后4小时达到最低血清胱抑素C浓度。
- 胱抑素C KFR和基线血肌酐预测死亡或透析或MAKE-F的AUC分别为0.73(95%CI 0.48-0.89)和0.71(95%CI 0.51-0.84)。
- 包含胱抑素C KFR、年龄、基线血肌酐和最低胱抑素C的模型预测eGFR下降>1.2 mL/min/年(MAKE-S)的AUC为0.89。
关键数值与推荐
- 胱抑素C KFR预测死亡或透析或MAKE-F的AUC为0.73(95%CI 0.48-0.89)。
- 基线血肌酐预测死亡或透析或MAKE-F的AUC为0.71(95%CI 0.51-0.84)。
- 联合模型预测MAKE-S(eGFR下降>1.2 mL/min/年)的AUC为0.89。
临床怎么用
- 系列胱抑素C测量可简化KFR评估,避免定时尿收集和放射性核素暴露,便于临床监测。
- 胱抑素C KFR和基线血肌酐可用于预测CKD患者死亡、透析或肾脏不良事件风险。
局限性
- 需要进一步验证胱抑素C KFR在更广泛CKD人群中的适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney functional reserve (KFR), the only clinical kidney stress test, is not routinely measured because the complexity of measurement has limited clinical application. We investigated the utility of plasma cystatin C (CysC) after oral protein loading (PL) to determine KFR in Stages 3 and 4 chronic kidney disease (CKD). METHODS: Following a 24-h low-protein diet, KFR was measured after oral protein by hourly plasma CysC and compared with simultaneous creatinine clearance (CrCl) and radionuclide 99technetium diethylenetriaminepentaacetatic acid (Tc-99m-DTPA) measured glomerular filtration rate (mGFR) measurement in an observational, single-centre cohort study of adults with CKD Stages 3 and 4. Subjects were followed for 3 years for fast (F) or slow (S) CKD progression, dialysis requirement or death or a combination of major adverse kidney events (MAKEs). RESULT: CysC, CrCl and Tc-99m-DTPA mGFR measurements of KFR in 19 CKD Stage 3 and 21 CKD Stage 4 patients yielded good agreement. KFR was not correlated with baseline kidney function. Eight CKD Stage 3 (42%) and 11 CKD Stage 4 (52%) subjects reached their lowest serum CysC concentration 4 h after PL. CysC KFR and baseline serum creatinine (sCr) predicted death or dialysis or MAKE-F with a respective area under the curve (AUC) of 0.73 [95% confidence interval (CI) 0.48-0.89] and 0.71 (95% CI 0.51-0.84). Including CysC KFR, age, baseline sCr and nadir CysC predicted a decrease in sCr-estimated GFR >1.2 mL/min/year (MAKE-S) with an AUC of 0.89. CONCLUSIONS: Serial CysC avoided timed urine collection and radionuclide exposure and yielded equivalent estimates of KFR. Serial CysC may facilitate monitoring of KFR in clinical practice.
引用
- Christiadi D, Simpson C, O'brien K, et al. Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease. Nephrol Dial Transplant. 2022. PMID: 34043011. doi:10.1093/ndt/gfab188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。